Brendan Saloner, PhD, is the Donald G. Millar Professor of Alcohol and Addiction Studies in the Department of Health Services, Policy, and Practice. One strand of his research focuses on access and quality of care for people with mental health and substance use disorders. He has received funding awards from the National Institute on Drug Abuse (NIDA) and Arnold Ventures to study opioid use disorder treatment, including recent grants to study the implementation of mobile methadone treatment in New York state and urine drug testing for patients with opioid use disorder. At Johns Hopkins, he co-led the evaluation team for the Bloomberg Overdose Prevention Initiative, a $120 million investment in overdose reduction focused on seven states.
A second strand of his research focuses specifically on health care for people in the criminal legal system. He has also received grants from NIDA and Arnold Ventures to investigate medications for opioid use disorder among incarcerated people. He is currently evaluating the statewide expansion of addiction treatment in Maryland county detention facilities. Finally, Professor Saloner maintains an active research program in bioethics. He led a Making a Difference grant supported by the Greenwall Foundation to study resource allocation in jails and prisons during the COVID-19 pandemic. He received the Greenwall Faculty Scholars Award in 2023 for a project focused on ethical issues related to mandated addiction treatment for people in the criminal legal system. Professor Saloner has an extensive interest in policy engagement. He has testified in the U.S. Senate, consulted with federal and state agencies, and has engaged in technical assistance projects.
Professor Saloner received his BA from the University of California, Berkeley and his PhD in Health Policy from Harvard University (ethics concentration). He was a Robert Wood Johnson Health and Society Scholar at the University of Pennsylvania.
